Drug Shortage Report for DEXTROSE INJECTION

Last updated on 2024-08-01

Report ID 223983
Drug Identification Number 02517132
Brand name DEXTROSE INJECTION
Common or Proper name DEXTROSE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 50%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2024-04-01
Actual start date 2024-04-01
Estimated end date 2024-08-31
Actual end date 2024-07-31
Shortage status Resolved
Updated date 2024-08-01
Company comments Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-08-01 French Compare
v12 2024-08-01 English Compare
v11 2024-07-23 French Compare
v10 2024-07-23 English Compare
v9 2024-07-02 French Compare
v8 2024-07-02 English Compare
v7 2024-06-04 French Compare
v6 2024-06-04 English Compare
v5 2024-04-02 English Compare
v4 2024-03-31 French Compare
v3 2024-03-31 English Compare
v2 2024-03-31 French Compare
v1 2024-03-30 English Compare

Showing 1 to 13 of 13